KLRC1 and COVID-19: Prior to performing NK cell cytotoxicity assays, we confirmed the expression of NKG2A and KIR2DL1 on the NK cells derived from COVID-19 positive patients utilized for these assays by flow cytometry (Supplemental Figure 1).